Notice Concerning Issuance of New Shares by way of Third-Party Allotment (A-2 Series)

2020.01.31

On January 31, 2020, the Company conducted a capital increase (Series A-2) by issuing new shares through a third-party allotment to three venture capital firms.

Participation in "Innovation Leaders Summit 2019" (Oct. 28-30).
Our company was introduced on the Kyoto Prefecture website.

Latest posts

2023.11.29 News
Participate and speak at the “Innovation Leaders Summit 2023” (Dec. 5).
2023.10.31 Press Release
The 8th Annual General Meeting of Shareholders was held.
2023.07.13 News
Participate and speak at the “KLSAP2023 Pitch Event” (Jul. 14).
2023.06.22 News
Notice of website maintenance
2023.06.01 IR
Head office moved to Kyoto City Growth Industry Creation Center (ACT Kyoto).
2022.11.01 Press Release
We will start joint research with Mochida Pharmaceutical Co. ,Ltd
2022.10.30 Press Release
We reported the financial results at the regular general meeting of shareholders.
2021.11.01 IR
Notice Concerning Issuance of Stock Acquisition Rights through Crowdfunding
2021.09.01 R&D
Research and development of exosomes will be resumed.
2021.03.16 News
“ACHIEVEMENTS” Page has been updated.

Latest posts

Participate and speak at the “Innovation Leaders Summit 2023” (Dec. 5).

The 8th Annual General Meeting of Shareholders was held.

Participate and speak at the “KLSAP2023 Pitch Event” (Jul. 14).

Notice of website maintenance

Head office moved to Kyoto City Growth Industry Creation Center (ACT Kyoto).

We will start joint research with Mochida Pharmaceutical Co. ,Ltd

We reported the financial results at the regular general meeting of shareholders.

Notice Concerning Issuance of Stock Acquisition Rights through Crowdfunding

Research and development of exosomes will be resumed.

“ACHIEVEMENTS” Page has been updated.